Keyphrases
Hepatocellular Carcinoma
100%
Cirrhosis
53%
Hepatic Encephalopathy
38%
Sorafenib
37%
Spain
24%
Hepatitis C Treatment
23%
White Matter Lesions
23%
Nodule
23%
Portal Vein Thrombosis
19%
Overall Survival
19%
Non-alcoholic Fatty Liver Disease (NAFLD)
18%
Cirrhotic Patients
17%
Minimal Hepatic Encephalopathy
16%
Adverse Events
14%
Advanced Hepatocellular Carcinoma
13%
Clinical Trials
13%
Clinical Characteristics
12%
Magnetic Resonance
11%
Ornithine Phenylacetate
11%
Plasma Ammonia
11%
High-fat Diet
11%
Hepatitis C Virus
11%
Elderly Patients
11%
Fibrolamellar Hepatocellular Carcinoma
11%
Cognitive Function
11%
Cause Analysis
11%
High-resolution
11%
Upper Gastrointestinal Bleeding
11%
Cell-free DNA (cfDNA)
11%
Liver Transplantation
11%
Genetic Profile
11%
HIV Infection
11%
Pork Meat
11%
Hepatitis C Virus Subtype
11%
Non-cirrhotic
11%
Hepatitis E Infection
11%
Atorvastatin
11%
Lipotoxicity
11%
Subtype Heterogeneity
11%
Screening Program
11%
Branched-chain Amino Acids
11%
Hepatic Tumorigenesis
11%
White Matter Volume
11%
Survival Events
11%
Ultra-deep Sequencing
11%
Natural History
11%
Dermatological Adverse Effects
11%
Amino Acid Supplementation
11%
Multi-cohort Studies
11%
Complete Response
11%
Medicine and Dentistry
Hepatocellular Carcinoma
64%
Hepatic Encephalopathy
46%
Liver Cirrhosis
36%
White Matter Lesion
23%
Non-Alcoholic Fatty Liver Disease
16%
Sorafenib
13%
Adverse Event
13%
Hepatology
12%
Cognition
12%
Liver Disease
12%
Screening
11%
Ornithine Phenylacetate
11%
Lipotoxicity
11%
Carcinogenesis
11%
Human Immunodeficiency Virus
11%
Human Immunodeficiency Virus Infection
11%
Hepatitis C
11%
Liver Transplantation
11%
Supplementation
11%
Isoniazid
11%
Dermatological Agent
11%
Upper Gastrointestinal Bleeding
11%
Liver Fibrosis
11%
Branched Chain Amino Acid
11%
Portal Vein Thrombosis
11%
High Fat Food
11%
Liver Cancer
11%
Glutamine
11%
Liver Carcinogenesis
9%
Magnetic Resonance Imaging
7%
Brain Edema
6%
Brain Disease
6%
Provocation Test
5%
Portosystemic Anastomosis
5%
Overall Survival
5%
Diseases
5%
